Literature DB >> 24236898

The background to this themed issue on neuropeptides.

Julie Keeble1.   

Abstract

UNLABELLED: A meeting of the British Pharmacological Society in association with the European Neuropeptide Club and Americal Summer Neuropeptide Conference in June 2012 led to this themed issue on neuropetides. A wide range of neuropeptides are discussed, in various physiological and pathophysiological conditions, with respect to their upstream and downstream pathways. It is clear, at this point in time, that targeting neuropeptides has therapeutic potential in pathologies ranging from migraine to obesity. It is also clear from the reviews in this issue of the British Journal of Pharmacology that there is still so much to learn. LINKED ARTICLES: This article is part of a themed section on Neuropeptides. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.170.issue-7.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  CGRP; GPCR; TRPV1; motilin; neuropeptides; pituitary adenylyl cyclase-activating peptide; substance P; vasoactive intestinal peptide

Mesh:

Substances:

Year:  2013        PMID: 24236898      PMCID: PMC3838675          DOI: 10.1111/bph.12474

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

Review 1.  Roles of proteolysis in regulation of GPCR function.

Authors:  G S Cottrell
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 2.  CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?

Authors:  C S Walker; D L Hay
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 3.  TRPV1 and SP: key elements for sepsis outcome?

Authors:  Jennifer Victoria Bodkin; Elizabeth Soares Fernandes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Authors:  J A Waschek
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 5.  Structure-activity relationships for α-calcitonin gene-related peptide.

Authors:  Harriet A Watkins; Dan L Rathbone; James Barwell; Debbie L Hay; David R Poyner
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 6.  Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.

Authors:  C K Boughton; K G Murphy
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.